comparison of glp-1 agonists History glucagon-like peptide-1 receptor TrimRX | Common Misconceptions About
Description
Tirzepatide was approved by the Food and Drug Administration in May 2022 for the treatment of T2D, and later in October received Fast Track designation for treatment of obesity
Cell Metab 34, 16541674 (2022)
Effects of exenatide (Exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
BMC Musculoskelet
Some will be mild but uncomfortable, such as cramping, and others will be more severe, such as shortness of breath
